aspsirna2261 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna2261
siRNA Name: P14
Gene:Cu,Zn superoxide dismutase (SOD1)
Disease:Amyotrophic Lateral Sclerosis (ALS)
Wild allele/target (5'->3'): ACUUGGGCAAUGUGACUGC
Mutant allele/target (5'->3'):ACUUGCGCAAUGUGACUGC
Target Mutation: c.256G>C,p.Gly86Arg
Wild siRNA (As strand):UGAACCCGUUACACUGACG
ASP-siRNA (As strand):UGAACGCGUUACACUGACG
Mismatch position in siRNA: G14C
Mutant allele (5'->3'): ACUUGCGCAAUGUGACUGC
ASP-siRNA (As strand):UGAACGCGUUACACUGACG
ASP-siRNA efficacy for mutant allele:88
Wild allele (5'->3'): ACUUGGGCAAUGUGACUGC
ASP-siRNA (As strand):UGAACGCGUUACACUGACG
ASP-siRNA efficacy for wild allele:10
Percentage discrimination for ASP-siRNA:78
Wild allele (5'->3'): ACUUGGGCAAUGUGACUGC
Wild siRNA (As strand):UGAACCCGUUACACUGACG
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): ACUUGGGCAAUGUGACUGC
ASP-siRNA (As strand):UGAACGCGUUACACUGACG
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:35
Concentration:50nM
Orientation:Antisense
Mismatch in:siRNA
UniProt ID: P00441
Target sequence: AGGCAUGUUGGAGACUUGGGCAAUGUGACUGCUGACAAAGAUGGU
Genbank Accesion: NM_000454.4
Cell-line: Drosophila embryo lysate
Experimental technique used: In vitro cleavage assay
Transfection method: Lipofectamine 2000
siRNA expression method: Chemically synthesized
Post-transfection duration: 2 hours
OMID ID: 105400
KEGG disease ID:H00058
Reference:US2007/0259827A1

.
.
.
.
.
.
.
.
.
.
.

.

.

.